×
About 717 results

ALLMedicine™ Prosthetic Heart Valves Center

Research & Reviews  349 results

Comparison of Different Anticoagulation Regimens Regarding Maternal and Fetal Outcomes ...
https://doi.org/10.1016/j.amjcard.2020.04.010
The American Journal of Cardiology; Güner A, Kalçık M et. al.

May 7th, 2020 - Mechanical prosthetic heart valves (MPHVs) are highly thrombogenic, and a pregnancy-induced procoagulant status increases the risk of MPHV thrombosis. Despite numerous case reports, 2 major registries and meta-analyses/systematic reviews, optimal ...

Management of acute coronary syndromes in patients with prosthetic heart valves.
https://doi.org/10.1017/S1047951120000979
Cardiology in the Young; Güner A, Kalçık M et. al.

Apr 23rd, 2020 - Management of acute coronary syndromes in patients with prosthetic heart valves.|2020|Güner A,Kalçık M,Yesin M,Özkan M,|

Computed Tomography Annular Dimensions: A Novel Method to Compare Prosthetic Valve Hemo...
https://doi.org/10.1016/j.athoracsur.2020.03.012
The Annals of Thoracic Surgery; Deeb GM, Popma JJ et. al.

Apr 14th, 2020 - Cardiac Surgical Societies Valve Labeling Task Force consensus document acknowledged inconsistent sizing and labelling of prosthetic heart valves. This study compared labeled size, internal diameter, and hemodynamics of different surgical and tran...

Cardiogenic shock due to leaflet migration of On-X® aortic mechanical prosthesis.
https://doi.org/10.1016/j.athoracsur.2020.01.023
The Annals of Thoracic Surgery; Göbel N, Tanriverdi S et. al.

Feb 26th, 2020 - Cardiogenic shock is a life-threatening condition requiring fast and efficient diagnostic and therapeutic measures. In this case, the history of several cardiac surgeries hindered finding the correct diagnosis initially. Only after indication of u...

Determinants of low-quality warfarin anticoagulation in patients with mechanical prosth...
https://doi.org/10.1111/bjh.16528
British Journal of Haematology References; Pastori D, Lip GYH et. al.

Feb 19th, 2020 - Quality of warfarin therapy in patients with a mechanical prosthetic heart valve (MPHV) has been barely investigated. We analysed determinants of low time in the therapeutic range (TiTR <60%) in 2111 patients with MPHVs from the nationwide PLECTRU...

see more →

Guidelines  2 results

Characteristics of surgical prosthetic heart valves and problems around labeling: A doc...
https://doi.org/10.1016/j.jtcvs.2019.04.001
The Journal of Thoracic and Cardiovascular Surgery; Durko AP, Head SJ et. al.

May 15th, 2019 - Intraoperative surgical prosthetic heart valve (SHV) choice is a key determinant of successful surgery and positive postoperative outcomes. Currently, many controversies exist around the sizing and labeling of SHVs rendering the comparison of diff...

Computational Fluid Dynamics Assessment Associated with Transcatheter Heart Valve Prost...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095731
Cardiovascular Engineering and Technology; Wei ZA, Sonntag SJ et. al.

Apr 20th, 2018 - The governing international standard for the development of prosthetic heart valves is International Organization for Standardization (ISO) 5840. This standard requires the assessment of the thrombus potential of transcatheter heart valve substitu...

see more →

Clinicaltrials.gov  359 results

Comparison of Different Anticoagulation Regimens Regarding Maternal and Fetal Outcomes ...
https://doi.org/10.1016/j.amjcard.2020.04.010
The American Journal of Cardiology; Güner A, Kalçık M et. al.

May 7th, 2020 - Mechanical prosthetic heart valves (MPHVs) are highly thrombogenic, and a pregnancy-induced procoagulant status increases the risk of MPHV thrombosis. Despite numerous case reports, 2 major registries and meta-analyses/systematic reviews, optimal ...

Management of acute coronary syndromes in patients with prosthetic heart valves.
https://doi.org/10.1017/S1047951120000979
Cardiology in the Young; Güner A, Kalçık M et. al.

Apr 23rd, 2020 - Management of acute coronary syndromes in patients with prosthetic heart valves.|2020|Güner A,Kalçık M,Yesin M,Özkan M,|

Computed Tomography Annular Dimensions: A Novel Method to Compare Prosthetic Valve Hemo...
https://doi.org/10.1016/j.athoracsur.2020.03.012
The Annals of Thoracic Surgery; Deeb GM, Popma JJ et. al.

Apr 14th, 2020 - Cardiac Surgical Societies Valve Labeling Task Force consensus document acknowledged inconsistent sizing and labelling of prosthetic heart valves. This study compared labeled size, internal diameter, and hemodynamics of different surgical and tran...

Cardiogenic shock due to leaflet migration of On-X® aortic mechanical prosthesis.
https://doi.org/10.1016/j.athoracsur.2020.01.023
The Annals of Thoracic Surgery; Göbel N, Tanriverdi S et. al.

Feb 26th, 2020 - Cardiogenic shock is a life-threatening condition requiring fast and efficient diagnostic and therapeutic measures. In this case, the history of several cardiac surgeries hindered finding the correct diagnosis initially. Only after indication of u...

Determinants of low-quality warfarin anticoagulation in patients with mechanical prosth...
https://doi.org/10.1111/bjh.16528
British Journal of Haematology References; Pastori D, Lip GYH et. al.

Feb 19th, 2020 - Quality of warfarin therapy in patients with a mechanical prosthetic heart valve (MPHV) has been barely investigated. We analysed determinants of low time in the therapeutic range (TiTR <60%) in 2111 patients with MPHVs from the nationwide PLECTRU...

see more →

News  7 results

FDA Drug Safety Communication: Pradaxa (dabigatran etexilate mesylate) should not be used in patients with mechanical prosthetic heart valves
https://www.fda.gov/Drugs/DrugSafety/ucm332912.htm

Comunicado de la FDA sobre la seguridad de los medicamentos: Pradaxa (dabigatrán etexilato mesilato) no se debe usar en pacientes con válvulas protésicas del corazón 1-800-332-1088 1-800-FDA-0178 Fax Report a Serious Problem MedWatch Online Regula...

FDA Drug Safety Communication: Safety review of post-market reports of serious bleeding events with the anticoagulant Pradaxa (dabigatran etexilate mesylate)
https://www.fda.gov/Drugs/DrugSafety/ucm282724.htm

FDA Drug Safety Communication: Pradaxa (dabigatran etexilate mesylate) should not be used in patients with mechanical prosthetic heart valves 12/19/2012 1-800-332-1088 1-800-FDA-0178 Fax Report a Serious Problem MedWatch Online Regular Mail: Use p...

Dental work tied to heart infections in people with artificial valves
https://www.reuters.com/article/us-health-heartvalves-dental-endocarditi/dental-work-tied-to-heart-infections-in-people-with-artificial-valves-idUSKCN1BP2UR

Sep 14th, 2017 - (Reuters Health) - Invasive dental procedures may raise the risk of rare but serious infections in people who have prosthetic heart valves, a recent French study suggests. Some previous research has linked dental work to an increased risk of what’...

GI Bleeding Linked To Dysfunctional Prosthetic Valves
https://www.medpagetoday.com/cardiology/pci/57243

Apr 7th, 2016 - Action Points Abnormal von Willebrand factor (VWF) levels can indicate the dysfunction of prosthetic heart valves, according to a study, and that condition has in turn been tied to gastrointestinal bleeding acquired from a surgery or transcatheter...

2012 Drug Safety Communications
https://www.fda.gov/Drugs/DrugSafety/ucm287414.htm

Pradaxa (dabigatran etexilate mesylate) should not be used in patients with mechanical prosthetic heart valves 12/19/2012 Serious skin reactions after combination treatment with the Hepatitis C drug Incivek (telaprevir), peginterferon alfa, and ri...

see more →